Table 1 Summary of IHC analysis of REGγ expression in multiple human cancer tissue
From: REGγ is associated with multiple oncogenic pathways in human cancers
REGγ Level | p value | |||||
|---|---|---|---|---|---|---|
Cancer type | Sample Amount | |||||
- | + | ++/+++ | -v.s + | -v.s ++/+++ | ||
lung cancer | 92 | 8 (8.7%) | 34 (37.0%) | 50 (54.3%) | 3.70E-04 | i.61E-13 |
colon cancer | 48 | 2 (4.2%) | 16 (33.3%) | 30 (62.5%) | 1.74E-04 | 8.63E-06 |
thyroid cancer | 49 | 2 (4.1%) | 16 (32.7%) | 31(63.3%) | 1.44E-01 | 7.09E-02 |
liver cancer | 206 | 5 (2.4%) | 36 (17.5%) | 165 (80.1%) | 5.68E-03 | 8.44E-07 |
total | 395 | 17 (4.3%) | 102 (25.8%) | 276 (69.9%) |